SCHEMBL2431131

SCHEMBL2431131

CN1CCN(c2ccc(CN)cc2F)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.51
▸ L3MBTL1 Q9Y468 2/20 0.51
▸ KDM4E B2RXH2 4/20 0.47
▸ NCF1 P14598 2/20 0.44
▸ MAPT P10636 6/20 0.44
▸ POLB P06746 2/20 0.44
▸ RAD52 P43351 1/20 0.44
▸ CA2 P00918 1/20 0.43
▸ CHKA P35790 1/20 0.43
▸ PRMT6 Q96LA8 1/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ MAPK1 P28482 2/20 0.42
▸ LMNA P02545 2/20 0.42
▸ GFER P55789 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ OPRL1 P41146 1/20 0.42
▸ GAA P10253 1/20 0.41
▸ HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29493267 1.00 ALDH1A1 (0.51) ALDH1A1L3MBTL1KDM4ENCF1MAPT
SCHEMBL29817954 0.87 ALDH1A1 (0.47) ALDH1A1L3MBTL1KDM4ENCF1MAPT
SCHEMBL8427926 0.85 ALDH1A1 (0.49) ALDH1A1L3MBTL1KDM4EMAPTPOLB
SCHEMBL4024455 0.85 ALDH1A1 (0.51) ALDH1A1MAPTPOLBRAD52PRMT6
SCHEMBL14922289 0.84 CHKA (0.50) ALDH1A1L3MBTL1KDM4EMAPTPOLB
SCHEMBL4027973 0.83 ALDH1A1 (0.50) ALDH1A1MAPTPOLBPRMT6NPC1
SCHEMBL4029065 0.83 ALDH1A1 (0.50) ALDH1A1MAPTPOLBPRMT6NPC1
SCHEMBL4023577 0.83 ALDH1A1 (0.50) ALDH1A1MAPTPOLBPRMT6NPC1
SCHEMBL14393569 0.83 ALDH1A1 (0.46) ALDH1A1L3MBTL1KDM4EMAPTPOLB
SCHEMBL4485868 0.82 MAPT (0.61) ALDH1A1L3MBTL1KDM4ENCF1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8012956-B2 Tropane compounds EXELIXIS, INC. (US) 2011-09-06 — — US disclosed
US-8012956-B2 Tropane compounds EXELIXIS, INC. (US) 2011-09-06 — — US disclosed
US-8012956-B2 Tropane compounds EXELIXIS, INC. (US) 2011-09-06 — — US disclosed
CN-101910168-A Tropane compounds EXELIXIS INC 2010-12-08 — — CN disclosed
EP-2074120-B1 TROPANE COMPOUNDS EXELIXIS INC (US) 2010-03-03 — — EP disclosed
EP-2074120-A1 TROPANE COMPOUNDS Exelixis, Inc. (US) 2009-07-01 — — EP disclosed
US-20090163471-A1 Tropane compounds EXELIXIS, INC. 2009-06-25 — — US disclosed
US-20090163471-A1 Tropane compounds EXELIXIS, INC. 2009-06-25 — — US disclosed
US-20090163471-A1 Tropane compounds EXELIXIS, INC. 2009-06-25 — — US disclosed
WO-2009055077-A1 TROPANE COMPOUNDS EXELIXIS, INC. (US) 2009-04-30 — — WO disclosed
WO-2009055077-A1 TROPANE COMPOUNDS EXELIXIS, INC. (US) 2009-04-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163471-A1 Tropane compounds ADRA1B, ADRA2B, ADRB2 ALDH1A1 323/4885L3MBTL1 960/4885KDM4E 4402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback